Merrimack Pharmaceuticals
MACK
#8373
Rank
ยฃ0.16 B
Marketcap
ยฃ11.31
Share price
0.00%
Change (1 day)
-1.88%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2024 (TTM): ยฃ10.97

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is ยฃ10.36. In 2016 the company made an earnings per share (EPS) of -ยฃ9.14 an increase over its 2015 EPS that were of -ยฃ9.87.

EPS history for Merrimack Pharmaceuticals from 2012 to 2024

Annual EPS

Year EPS Change
2024 (TTM)ยฃ10.97
2016-ยฃ9.14-7.35%
2015-ยฃ9.8765%
2014-ยฃ5.98-39.39%
2013-ยฃ9.87-54.01%
2012-ยฃ21.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
ยฃ2.77-73.26%๐Ÿ‡ซ๐Ÿ‡ท France
AVEO Oncology
AVEO
-ยฃ0.63-106.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-ยฃ0.08969-100.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
-ยฃ1.41-113.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ57.34-653.46%๐Ÿ‡บ๐Ÿ‡ธ USA